SOPHiA GENETICS WEBINAR : PREVENT

PREVENT: going beyond current paradigms for breast cancer risk assessment

Breast cancer is a major public health concern and early detection might allow both less aggressive care and higher expectation of cure. Screening for breast cancer through mammography is well accepted in most countries. Because screening mammography is less effective among younger women, the cost effectiveness models have suggested a threshold of 50 years old to begin the screening program. On the other hand, a substantial proportion of breast cancers occurs in women between the ages of 40 and 55. There is a medical need to identify women at higher risk of breast cancer.

This webinar will describe PREVENT, the new solution developed by SOPHiA GENETICS, that incorporates genetic and non-genetic risk factors into a simple to use test. PREVENT provides physicians with a more precise estimation of breast cancer risk and supports personalized screening plans and preventive measures.

In the first part of the webinar, Dr. David Cox, the SOPHiA GENETICS’ Clinical Application Product Manager who has developed PREVENT, will cover the scientific background and technical details of this breast cancer risk assessment test.

Then, Pr. Xavier Pivot, General Director of the Paul Strauss Center, will describe the clinical utility of PREVENT, and how it will fit into the breast cancer program at the Paul Strauss Center.